Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study

[1]  Simon Capewell,et al.  Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. , 2007, Journal of the American College of Cardiology.

[2]  J. Pankow,et al.  Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance , 2007, Diabetes Care.

[3]  T. Rea,et al.  Diabetes, glucose level, and risk of sudden cardiac death. , 2005, European heart journal.

[4]  Seppo Lehto,et al.  Gender difference in the impact of type 2 diabetes on coronary heart disease risk. , 2004, Diabetes care.

[5]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[6]  JoAnn E. Manson,et al.  Prospective Study of Sudden Cardiac Death Among Women in the United States , 2003, Circulation.

[7]  George A. Mensah,et al.  Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.

[8]  J. Moses,et al.  Transcatheter therapeutic embolization of multiple coronary artery fistulas. , 2001, Circulation.

[9]  D R Jacobs,et al.  Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997: The Minnesota Heart Survey , 2001, Circulation.

[10]  X. Jouven,et al.  Diabetes as a risk factor for sudden death , 1999, The Lancet.

[11]  A. Folsom,et al.  Sex and race differences in short-term prognosis after acute coronary heart disease events: the Atherosclerosis Risk In Communities (ARIC) study. , 1999, American heart journal.

[12]  P Ducimetière,et al.  Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.

[13]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.

[14]  C. Caspersen,et al.  Risk Factors for Sudden Coronary Death in the United States , 1997, Epidemiology.

[15]  Paul D. Allison,et al.  Survival analysis using sas®: a practical guide , 1995 .

[16]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[17]  K. Wu,et al.  ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies , 1989, Thrombosis and Haemostasis.

[18]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[19]  L. Wilhelmsen,et al.  Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. , 1987, European heart journal.

[20]  R. Virmani,et al.  Sudden cardiac death. , 1987, Human pathology.

[21]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[22]  J. Albers,et al.  HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. , 1982, American journal of clinical pathology.

[23]  R. Wenk,et al.  Simple, rapid, kinetic method for serum creatinine measurement. , 1972, Clinical chemistry.

[24]  Neil R. Powe,et al.  The Atherosclerosis Risk in Communities Study , 2006 .

[25]  Deeb N Salem,et al.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.

[26]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[27]  S Greenland,et al.  The impact of confounder selection criteria on effect estimation. , 1989, American journal of epidemiology.